Work demonstrates tunable broadband near-infrared emission in phosphors, highlighting the role of site-selective occupation and cation substitution.
In this work, a series of Eu²⁺-doped SrLa₂Sc₂O₇ phosphors were rationally designed and synthesized, exhibiting high photoluminescence quantum yields and excellent thermal stability. Under 440 nm blue-light excitation, these phosphors show a broad red emission band centered at 613 nm, with a full width at half-maximum (fwhm) of 81 nm (corresponding to ∼0.26 eV at ∼613 nm). By employing a Sr²⁺/Ba²⁺ substitution strategy to modulate the local crystal field around Eu²⁺, both a redshift in the emission peak and significant spectral broadening were achieved. Notably, complete substitution of Sr²⁺ with Ba²⁺ yielded a BaLa₂Sc1.985O₇:0.015Eu²⁺ phosphor that exhibits a broadband near-infrared (NIR) emission peaking at 812 nm with an ultrabroad fwhm of 318 nm (corresponding to ∼0.59 eV at ∼812 nm). Moreover, aliovalent substitution of Eu²⁺ for Sc³⁺ generates oxygen-vacancy-related defect centers that act as carrier traps, extending the emission lifetime and enhancing resistance to thermal quenching in SrLa₂Sc1.985O₇:0.015Eu²⁺. In addition, incorporation of larger Ba²⁺ ions softens the host lattice, strengthening excited-state lattice relaxation and electron-phonon coupling, thereby increasing the Stokes shift and further broadening the Eu²⁺ emission band to realize tunable broadband red-to-NIR emission in Eu²⁺-activated Sr1-xBaxLa₂Sc₂O₇ phosphors. These findings broaden the family of Eu²⁺-activated scandate oxide phosphors and provide a viable strategy for tuning broadband NIR emission via targeted cation substitution devices.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: